| 臺大學術典藏 |
2020-05-25T07:35:13Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Chia-Chi Lin; Shih J.-Y; Yu C.-J; Ho C.-C; Liao W.-Y; Lee J.-H; Tsai T.-H; Su K.-Y; Hsieh M.-S; Chang Y.-L; Bai Y.-Y; Huang D.D.-R; Thress K.S; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:13Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y; Yang C.-Y; Liao B.-C; Ho C.-C; Liao W.-Y; Chen K.-Y; Tsai T.-H; Hsu C.-L; Hsu W.-H; Su K.-Y; Chang Y.-L; Lee J.-H; Chia-Chi Lin; Shih J.-Y; Yang J.C; Yu C.-J. |
| 臺大學術典藏 |
2020-05-25T07:35:03Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H; Shih J.-Y; Yang C.-Y; Liao W.-Y; Ho C.-C; Chen K.-Y; Tsai T.-H; Hsu C.-L; Liu Y.-N; Su K.-Y; Chang Y.-L; Wu C.-T; Liao B.-C; Hsu C.-C; Hsu W.-H; Lee J.-H; Chia-Chi Lin |
| 臺大學術典藏 |
2020-05-25T07:35:02Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y; Liao W.-Y; Ho C.-C; Chen K.-Y; Tsai T.-H; Hsu C.-L; Su K.-Y; Chang Y.-L; Wu C.-T; Hsu C.-C; Liao B.-C; Hsu W.-H; Lee J.-H; Chia-Chi Lin; Shih J.-Y; Yang J.C.-H; Yu C.-J. |
| 臺大學術典藏 |
2020-04-08T01:10:30Z |
The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
|
Yu, S.-L.; Yang, T.-Y.; Chang, G.-C.; Chang, G.-C.;Yang, T.-Y.;Yu, S.-L.;Chen, H.-W.;Chen, J.J.W.;Su, K.-Y.;Hsu, C.-H.;Chen, K.-C.;Tseng, J.-S.;Hsu, K.-H.;Huang, Y.-H.; Huang, Y.-H.; Hsu, K.-H.; Tseng, J.-S.; Chen, K.-C.; Hsu, C.-H.; Su, K.-Y.; Chen, J.J.W.; Chen, H.-W. |
| 臺大學術典藏 |
2020-03-30T08:50:58Z |
JAG1 is associated with poor survival through inducing metastasis in lung cancer
|
Chang W.-H.;Ho B.-C.;Hsiao Y.-J.;Jin-Shing Chen;Yeh C.-H.;Chen H.-Y.;Chang G.-C.;Su K.-Y.;Yu S.-L.; Chang W.-H.; Ho B.-C.; Hsiao Y.-J.; JIN-SHING CHEN; Yeh C.-H.; Chen H.-Y.; Chang G.-C.; Su K.-Y.; Yu S.-L. |
| 臺大學術典藏 |
2020-03-30T08:50:56Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Wang C.-L.; Chen K.-C.; Hsu K.-H.; Yang T.-Y.; Tseng J.-S.; Tseng C.-H.; Chiang C.-J.; Tseng C.-H.;Chiang C.-J.;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.H.;Tsai C.-M.;Huang M.-S.;Ho C.-C.;Yu C.-J.;Tsai Y.-H.;Jin-Shing Chen;Chou T.-Y.;Tsai M.-H.;Chen H.-Y.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Liu T.-W.;Chang G.-C.; Chang G.-C.; Yu S.-L.; Liu T.-W.; Chen H.-W.; Chen J.J.W.; Su K.-Y.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; Ho C.-C.; Yu C.-J.; Tsai Y.-H.; JIN-SHING CHEN; Chou T.-Y.; Tsai M.-H.; Chen H.-Y. |
| 臺大學術典藏 |
2020-03-30T08:50:50Z |
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer
|
Hsieh M.-S.; JIN-SHING CHEN; Yu S.-L.; Lee Y.-H.; Lin J.-W.; Lin M.-W.;Su K.-Y.;Su T.-J.;Chang C.-C.;Lin J.-W.;Lee Y.-H.;Yu S.-L.;Jin-Shing Chen;Hsieh M.-S.; Lin M.-W.; Su K.-Y.; Su T.-J.; Chang C.-C. |
| 臺大學術典藏 |
2020-03-27T05:28:42Z |
Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS
|
PO-REN HSUEH; Yu S.-L.; Liu J.-L.; Jou R.; Chang S.-Y.; Yu S.-L.;PO-REN HSUEH;Liu J.-L.;Jou R.;Chang S.-Y.;Yu C.-J.;Chiu H.-C.;Yan B.-S.;Su K.-Y.; Su K.-Y.; Yan B.-S.; Chiu H.-C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-24T03:47:56Z |
Mortality association between obesity and pneumonia using a dual restricted cohort model
|
Hassani D.;Kirby J.J.;Su K.-Y.;Robinson R.D.;Hsu W.-T.;Chou E.H.;CHIEN-CHANG LEE;Wang H.; Wang H.; CHIEN-CHANG LEE; Chou E.H.; Hsu W.-T.; Robinson R.D.; Su K.-Y.; Kirby J.J.; Hassani D. |
| 臺大學術典藏 |
2020-03-09T06:08:08Z |
Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice
|
Wu S.-L.;Wei T.-Y.;Shu-Wen Lin;Su K.-Y.;Kuo C.-H.; Wu S.-L.; Wei T.-Y.; SHU-WEN LIN; Su K.-Y.; Kuo C.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:37Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; YIH-LEONG CHANG; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; Yuan S. ;Yu S.-L. ;Chen H.-Y. ;Hsu Y.-C. ;Su K.-Y. ;Chen H.-W. ;Chen C.-Y. ;Yu C.-J. ;Shih J.-Y. ;Yih-Leong Chang ;Cheng C.-L. ;Hsu C.-P. ;Hsia J.-Y. ;Lin C.-Y. ;Wu G. ;Liu C.-H. ;Wang C.-D. ;Yang K.-C. ;Chen Y.-W. ;Lai Y.-L. ;Hsu C.-C. ;Lin T.-C. ;Yang T.-Y. ;Chen K.-C. ;Hsu K.-H. ;Chen J.J.W. ;Chang G.-C. ;Li K.-C. ;Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:34Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai T.-H.; Su K.-Y.; Wu S.-G.; YIH-LEONG CHANG; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:28Z |
Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer
|
Chen C.-C.;Chen H.-Y.;Su K.-Y.;Hong Q.-S.;Yan B.-S.;Chen C.-H.;Pan S.-H.;Yih-Leong Chang;Wang C.-J.;Hung P.-F.;Yuan S.;Chang G.-C.;Chen J.J.W.;Yang P.-C.;Yang Y.-C.;Yu S.-L.; Chen C.-C.; Chen H.-Y.; Su K.-Y.; Hong Q.-S.; Yan B.-S.; Chen C.-H.; Pan S.-H.; YIH-LEONG CHANG; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; Yang P.-C.; Yang Y.-C.; Yu S.-L. |
| 臺大學術典藏 |
2020-03-07T06:56:12Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Yih-Leong Chang;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:12Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Yih-Leong Chang;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-07T06:56:09Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Yih-Leong Chang;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T08:25:30Z |
Decreased expressions of hepsin in human hepatocellular carcinomas
|
Tsai Y.-C.; Cheng K.-C.; YUNG-MING JENG; Sheu J.-C.; Lin S.-W.; Su Y.-H.; Tao M.-H.; Su K.-Y.; Chen C.-H.; Chen C.-H.;Su K.-Y.;Tao M.-H.;Lin S.-W.;Su Y.-H.;Tsai Y.-C.;Cheng K.-C.;Yung-Ming Jeng;Sheu J.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:24Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; YIH-LEONG CHANG; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:21Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai T.-H.; Su K.-Y.; Wu S.-G.; YIH-LEONG CHANG; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:17Z |
Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer
|
Chen C.-C.; Chen H.-Y.; Su K.-Y.; Hong Q.-S.; Yan B.-S.; Chen C.-H.; Pan S.-H.; YIH-LEONG CHANG; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; Yang P.-C.; Yang Y.-C.; Yu S.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:04Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T05:26:03Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:00Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-05T08:04:01Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; MIN-SHU HSIEH; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Min-Shu Hsieh;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:59Z |
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer
|
Lin M.-W.;Su K.-Y.;Su T.-J.;Chang C.-C.;Lin J.-W.;Lee Y.-H.;Yu S.-L.;Chen J.-S.;Min-Shu Hsieh; Lin M.-W.; Su K.-Y.; Su T.-J.; Chang C.-C.; Lin J.-W.; Lee Y.-H.; Yu S.-L.; Chen J.-S.; MIN-SHU HSIEH |
| 臺大學術典藏 |
2020-02-11T07:58:43Z |
Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice
|
Hsu Y.-C.; Huang H.-P.; Yu I.-S.; Su K.-Y.; Lin S.-R.; Lin W.-C.; Wu H.-L.; Shi G.-Y.; Tao M.-H.; Kao C.-H.; YAO-MING WU; Martin P.E.; Lin S.-Y.; Yang P.-C.; Lin S.-W. |
| 臺大學術典藏 |
2020-01-21T01:20:43Z |
Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E
|
Ho B.-C. ;Yu S.-L. ;Chen J.J.W. ;Chang S.-Y. ;Bo-Shiun Yan ;Hong Q.-S. ;Singh S. ;Kao C.-L. ;Chen H.-Y. ;Su K.-Y. ;Li K.-C. ;Cheng C.-L. ;Cheng H.-W. ;Lee J.-Y. ;Lee C.-N. ;Yang P.-C.; Ho B.-C.; Yu S.-L.; Chen J.J.W.; Chang S.-Y.; BO-SHIUN YAN; Hong Q.-S.; Singh S.; Kao C.-L.; Chen H.-Y.; Su K.-Y.; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; Yang P.-C. |
| 臺大學術典藏 |
2020-01-21T01:20:42Z |
Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer
|
Chen C.-C.; Chen H.-Y.; Su K.-Y.; Hong Q.-S.; BO-SHIUN YAN; Chen C.-H.; Pan S.-H.; Chang Y.-L.; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; Yang P.-C.; Yang Y.-C.; Yu S.-L. |
| 臺大學術典藏 |
2020-01-21T01:20:41Z |
Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS
|
Su K.-Y.;Bo-Shiun Yan;Chiu H.-C.;Yu C.-J.;Chang S.-Y.;Jou R.;Liu J.-L.;Hsueh P.-R.;Yu S.-L.; Su K.-Y.; BO-SHIUN YAN; Chiu H.-C.; Yu C.-J.; Chang S.-Y.; Jou R.; Liu J.-L.; Hsueh P.-R.; Yu S.-L. |
| 臺大學術典藏 |
2020 |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020 |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yu C.-J.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; TZU-HSIU TSAI; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H. |
| 臺大學術典藏 |
2020 |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Su K.-Y.; Chang Y.-L.; Liu Y.-N.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020 |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yu C.-J.; Yang J.C.-H.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020 |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020 |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; CHIA-LIN HSU; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020 |
Copy number alterations of depressed colorectal neoplasm predict the survival and response to oxaliplatin in proximal colon cancer
|
Shun C.-T.; Liang J.-T.; Yu S.-L.; MING-SHIANG WU; Su K.-Y.; Chiu W.-T.; Hsu Y.-C.; Ho B.-C.; Chen M.-H.; Chiu H.-M.; Chang L.-C. |
| 臺大學術典藏 |
2019-12-26T06:40:12Z |
Comment on "modeling galaxy halos using dark matter with pressure"
|
Su, K.-Y.; Su, K.-Y.; PISIN CHEN |
| 臺大學術典藏 |
2019-07-29T08:52:43Z |
Perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure are associated with DNA methylation changes lasting to early adulthood: Findings from Yucheng second generation
|
Su K.-Y.;Li M.-C.;Lee N.-W.;Ho B.-C.;Cheng C.-L.;Chuang Y.-C.;Yu S.-L.;Yue-Liang Guo; Su K.-Y.; Li M.-C.; Lee N.-W.; Ho B.-C.; Cheng C.-L.; Chuang Y.-C.; Yu S.-L.; YUE-LIANG GUO |
| 臺大學術典藏 |
2019 |
The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
|
Su Y.-C.; Su K.-Y.; Lin K.-H.; Chen Y.-C.; Lee M.-Y.; Yu M.-S.; Wang C.-C.; Lin S.-C.; Tan T.-D.; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Chou S.-W.; Lin D.-T.; Jou S.-T.; Yao M.; Li C.-C.; Yeh S.-P.; Chen M.-H.; Gau J.-P.; Li S.-S.; Wang T.-F.; Liu Y.-C.; Wang P.-N.; CHIEN-CHANG LEE; Lin K.-H.;Su K.-Y.;Su Y.-C.;Chen Y.-C.;Lin S.-C.;Wang C.-C.;Yu M.-S.;Lee M.-Y.;Tan T.-D.;Wang T.-F.;Liu Y.-C.;Wang P.-N.;Li S.-S.;Gau J.-P.;Chen M.-H.;Yeh S.-P.;Li C.-C.;Yao M.;Jou S.-T.;Lin D.-T.;Chou S.-W.;Yang Y.-L.;Lu M.-Y.;Chang H.-H.;CHIEN-CHANG LEE |
| 臺大學術典藏 |
2019 |
The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
|
Li S.-S.; Wang P.-N.; Gau J.-P.; Chen M.-H.; Yeh S.-P.; Li C.-C.; Yao M.; Jou S.-T.; Lin D.-T.; Chou S.-W.; Lee C.-C.; HSIU-HAO CHANG; Lu M.-Y.; Yang Y.-L.; Lee C.-C.;Hsiu-Hao Chang;Lu M.-Y.;Yang Y.-L.;Chou S.-W.;Lin D.-T.;Jou S.-T.;Yao M.;Li C.-C.;Yeh S.-P.;Chen M.-H.;Gau J.-P.;Li S.-S.;Wang P.-N.;Liu Y.-C.;Wang T.-F.;Tan T.-D.;Lee M.-Y.;Yu M.-S.;Wang C.-C.;Lin S.-C.;Chen Y.-C.;Su Y.-C.;Su K.-Y.;Lin K.-H.; Su Y.-C.; Su K.-Y.; Lin K.-H.; Chen Y.-C.; Liu Y.-C.; Wang T.-F.; Tan T.-D.; Lee M.-Y.; Yu M.-S.; Wang C.-C.; Lin S.-C. |
| 臺大學術典藏 |
2019 |
The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
|
Chou S.-W.; Yang Y.-L.; Lu M.-Y.; Chang H.-H.; Lee C.-C.; Lin K.-H.; Su K.-Y.; Su Y.-C.; Chen Y.-C.; Lin S.-C.; Wang C.-C.; Yu M.-S.; Lee M.-Y.; Tan T.-D.; Wang T.-F.; Lin D.-T.; Jou S.-T.; MING YAO; Li C.-C.; Yeh S.-P.; Chen M.-H.; Gau J.-P.; Li S.-S.; Wang P.-N.; Liu Y.-C. |
| 臺大學術典藏 |
2019 |
The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
|
Chou S.-W.; Lin D.-T.; Yang Y.-L.; Lu M.-Y.; Chang H.-H.; Lee C.-C.; Lin K.-H.; Su K.-Y.; Su Y.-C.; Chen Y.-C.; Lin S.-C.; Wang C.-C.; Yu M.-S.; Lee M.-Y.; SHIANN-TANG JOU; Yao M.; Li C.-C.; Yeh S.-P.; Chen M.-H.; Gau J.-P.; Li S.-S.; Wang P.-N.; Liu Y.-C.; Wang T.-F.; Tan T.-D. |
| 國立成功大學 |
2019 |
The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
|
Lee, C.-C.;Chang, H.-H.;Lu, M.-Y.;Yang, Yang Y.-L.;Chou, S.-W.;Lin, D.-T.;Jou, S.-T.;Yao, M.;Li, C.-C.;Yeh, S.-P.;Chen, M.-H.;Gau, J.-P.;Li, S.-S.;Wang, P.-N.;Liu, Y.-C.;Wang, T.-F.;Tan, Tan T.-D.;Lee, M.-Y.;Yu, M.-S.;Wang, C.-C.;Lin, S.-C.;Chen, Y.-C.;Su, Y.-C.;Su, K.-Y.;Lin, K.-H. |
| 臺大學術典藏 |
2018-09-10T15:38:30Z |
Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients
|
SUNG-LIANG YU; KANG-YI SU; HUEI-WEN CHEN; Huang, Y.-H.;Hsu, K.-H.;Tseng, J.-S.;Chen, K.-C.;Su, K.-Y.;Chen, H.-Y.;Chang, C.-S.;Chen, J.J.W.;Yu, S.-L.;Chen, H.-W.;Yang, T.-Y.;Chang, G.-C. |
| 臺大學術典藏 |
2018-09-10T15:35:59Z |
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
|
Chang, W.-H.; Su, K.-Y.; Ku, W.-H.; Chang, G.-C.; Hong, Q.-S.; Hsiao, Y.-J.; Chen, H.-C.; Chen, H.-Y.; Wu, R.; Yang, P.-C.; Chen, J.J.W.; Yu, S.-L.; Chen, C.-H.; SUNG-LIANG YU; KANG-YI SU; 楊泮池et al. |
| 臺大學術典藏 |
2018-09-10T15:23:42Z |
Ant Colony Optimization-Based Adaptive Network-on-Chip Routing Framework Using Network Information Region
|
Hsin, H.-K.;Chang, E.-J.;Su, K.-Y.;Wu, A.-Y.A.; Hsin, H.-K.; Chang, E.-J.; Su, K.-Y.; Wu, A.-Y.A.; AN-YEU(ANDY) WU |
| 臺大學術典藏 |
2018-09-10T09:22:55Z |
ACO-based Deadlock-Aware fully-adaptive routing in Network-on-Chip systems
|
Su, K.-Y.; Hsin, H.-K.; Chang, E.-J.; Wu, A.-Y.; AN-YEU(ANDY) WU |
| 臺大學術典藏 |
2018-09-10T09:13:23Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai, T.-H. and Su, K.-Y. and Wu, S.-G. and Chang, Y.-L. and Luo, S.-C. and Jane, I.-S. and Yu, C.-J. and Yue, S.-L. and Shih, J.-Y. and Yang, P.-C.; Tsai, T-H.;Su, K-Y.;Wu, S-G.;Chang, Y-L.;Luo, S-C.;Jan, I-S.;Yu, C-J.;Yu, S-L.;Shih, J-Y.;Yang, P-C.; 俞松良 ;詹一秀 ;張逸良 ;楊泮池 ;余忠仁 ;吳尚俊 ;蔡子修 ;施金元; Tsai, T-H.; YIH-LEONG CHANG; Tsai, T-H.; Chong-Jen Yu; Su, K-Y.; Wu, S-G.; Wu, S-G.; KANG-YI SU; JIN-YUAN SHIH; Chang, Y-L.; Luo, S-C.; Luo, S-C.; Jan, I-S.; Jan, I-S.; Yu, C-J.; Yu, S-L.; Shih, J-Y.; Shih, J-Y.; Yang, P-C.; 楊泮池 |
| 臺大學術典藏 |
2018 |
FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression
|
Hsiao Y.-J.; Su K.-Y.; Chen H.-Y.; Lin C.-Y.; JIN-SHING CHEN; Chen Y.-J.; Hong Q.-S.; Ku W.-H.; Wu C.-Y.; Ho B.-C.; Chiang C.-C.; Yang P.-C.; Yu S.-L.; Hsu Y.-C.; Chen Y.-J.; Chang G.-C.; Hsu C.-Y.; Hsu C.-Y.;Chang G.-C.;Chen Y.-J.;Hsu Y.-C.;Hsiao Y.-J.;Su K.-Y.;Chen H.-Y.;Lin C.-Y.;Jin-Shing Chen;Chen Y.-J.;Hong Q.-S.;Ku W.-H.;Wu C.-Y.;Ho B.-C.;Chiang C.-C.;Yang P.-C.;Yu S.-L. |
